Director · Phio Pharmaceuticals Corp. · Common Stock, $.0001 par value
Side
BUY
Value
$17K
Shares
15.0K
Price
$1.14
Executed
Aug 19, 2026
Disclosed
Aug 20, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 19 executedAug 20, 2026 disclosed
PHIO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Plott Ronald Todd filed this Form 4 reporting a open-market purchase of PHIO on Aug 19, 2026. It became public on Aug 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Plott Ronald Toddcik:0001768337
Issuer
Phio Pharmaceuticals Corp.cik:0001533040
Revision history · 0
No field has changed since this record was first ingested.
